Clinical effectiveness of a patient decision aid to improve decision quality and glycaemic control in people with diabetes making treatment choices: A cluster randomised controlled trial (PANDAs) in general practice

BMJ Open

Volumn 2, Issue 6, 2012, Pages

  Mathers, Nigel ^a   Ng, Chirk Jenn ^b   Campbell, Michael Joseph ^c   Colwell, Brigitte ^a   Brown, Ian ^d   Bradley, Alastair ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; CLUSTER ANALYSIS; CONSULTATION; CONTROL PREFERENCE SCALE; CONTROLLED STUDY; DECISIONAL CONFLICT SCALE; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE DURATION; EXPECTATION; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; GLYCEMIC CONTROL; HEALTH CARE PERSONNEL; HUMAN; INSULIN TREATMENT; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MARKETING; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE; OUTCOMES RESEARCH; PANDAS DECISION AID; PATIENT AUTONOMY; PATIENT DECISION AID; PATIENT DECISION MAKING; PHYSICIAN; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SELF REPORT; STAFF TRAINING; STATISTICAL ANALYSIS; UNITED KINGDOM;

EID: 84870994007     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001469     Document Type: Article

References (38)

1. Diabetes UK. Diabetes in the UK 2011/2012: Key statistics on diabetes. http://www.diabetes.org.uk/Documents/Reports/Diabetes-in-the-UK-2011-12.pdf (accessed 12 Mar 2012).
2. Diabetes.co.uk. Cost of Diabetes. http://www.diabetes.co.uk/cost-of- diabetes.html (accessed 12 Mar 2012).
3. National Institute for Health and Clinical Excellence (NICE). Type 2 diabetes: newer agents. London: NICE, 2009.
4. UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
5. Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulphonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 1999;281:2005-12. (Pubitemid 29254858)
6. Fitgerald JT, Vijan S, Stuart N. Insulin therapy and patient attitudes at two VA centers. Diabetes 2000;49:A445.
7. Lauritzen T, Scott A. Barrier to insulin therapy in type 2 diabetes: a qualitative focus group research among patients, GPs and diabetologists. Eur Union Gen Pract Clin J 2002;3:33-40.
8. Jeavons D, Hungin AP, Cornford CS. Patients with poorly controlled diabetes in primary care: healthcare clinicians' beliefs and attitudes. Postgrad Med J 2006;82:347-50. (Pubitemid 43786048)
9. Paling J. Strategies to help patients understand risks. BMJ 2003;27:745-8. (Pubitemid 37176764)
10. Siriwardena AN. Clinical guidelines in primary care: a survey of general practitioners' attitudes and behaviour. Br J Gen Pract 1995;45:643-7. (Pubitemid 26002504)
11. Stacey D, Bennett CL, Barry MJ, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2011; CD001431.
12. Colwell B, Mathers N, Ng CJ, et al. Improving recruitment to primary care trials: some lessons from the use of modern marketing techniques. Debate and Analysis Paper. BJGP 2012;62:496-8. doi:
13. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:979-83.
14. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science 1981;211:453-8. (Pubitemid 11145313)
15. O'Connor AM, Tugwell P, Wells GA, et al. A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. Patient Educ Couns 1998;33:267-79. (Pubitemid 28168092)
16. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making 1995;15:25-30.
17. Janis IL, Mann L. Decision making: a psychological analysis of conflict, choice and commitment. New York: Free Press, 1977.
18. Degner LF, Sloan JA, Venkatesh P. The Control Preferences Scale. Can J Nurs Res 1997;29:21-43. (Pubitemid 127473357)
19. Davidson BJ, Degner LF, Morgan TR. Information and decision making preferences of men with prostate cancer. Oncol Nurs Forum 1995;22:1401-8.
20. Kremer H, Ironson G. Measuring the involvement of people with HIV in treatment decision making using the Control Preference Scale. Med Decis Making 2008;28:899-908.
21. Brehaut JC, O'connor AM, Wood TJ, et al. Validation of a decision regret scale. Med Decis Making 2003;23:281-92.
22. Kinmonth AL, Woodcock A, Griffin S, et al. Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. BMJ 1998;317:1202-8. (Pubitemid 28488511)
23. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. BMJ 2002;325:746-51.
24. Campbell MK, Elbourne DR, Altman DG for the CONSORT Group. CONSORT statement: extension to cluster randomised trials. BMJ 2004;328:702-8. (Pubitemid 38393415)
25. Elwyn G, O'Connor A, Stacey D, et al. International Patient Decision Aids Standards (IPDAS) Collaboration. Developing a quality criteria framework for patient decision aid: online international Delphi consensus process. BMJ 2006;333:417-19. (Pubitemid 44320126)
26. Légaré F, O'Connor AM, Graham ID, et al. Primary health care professionals' views on barriers and facilitators to the implementation of the Ottawa Decision Support Framework in practice. Patient Educ Couns 2006;63:380-90. (Pubitemid 44511877)
27. Karter AJ, Subramanian U, Saha C, et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care 2010;33:733-5.
28. Larkin ME, Capasso VA, Chen CL, et al. Measuring psychological insulin resistance: barriers to insulin use. Diabetes Educ 2008;34:511-17.
29. Auvinen A, Vornanen T, Tammela TL, et al. A randomized trial of the choice of treatment in prostate cancer: design and baseline characteristics. BJU Int 2001;88:708-15.
30. Murray E, Davis H, Tai SS, et al. Randomised controlled trial of an interactive multimedia decision aid on benign prostatic hypertrophy in primary care. BMJ 2001;323:493-6. (Pubitemid 32822295)
31. Cochrane Library. Cochrane Inventory of Patient Decision Aids. http://decisionaid.ohri.ca/cochinvent.php (accessed 12 Mar 2012).
32. Bradley A, Brown I, Ng CJ, et al. Decision aids in patients with type 2 diabetes considering treatment options: qualitative analysis of consultations and interviews from the PANDAs study. Diabet Med 2011;2(S1):118.
33. O'Cathain A, Thomas KJ. Evaluating decision aids - where next? Health Expect 2004;7:98-103. (Pubitemid 38661164)
34. O'Donnell S, Cranney A, Jacobsen MJ, et al. Understanding and overcoming the barriers of implementing patient decision aids in clinical practice. J Eval Clin Practice 2006;12:174-81. (Pubitemid 43384614)
35. O'Connor AM, Wennberg JE, Legare F, et al. Toward the 'tippingpoint': decision aids and informed patient choice. Health Aff (Millwood) 2007;26:716-25.
36. O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2009;(3). CD001431.
37. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1998;1:2-4.
38. Mathers N, Roberts S, Hodkinson I, et al. Care planning: improving the lives of people with long term conditions. UK: Royal College of General Practitioners, 2011.